Incidence of pancreatic cancer in people under 50 is projected to rise significantly in the coming decades, according to a study by Brazilian and Canadian researchers published in JCO Global Oncology.
The analysis, based on Global Burden of Diseases data from 204 countries and territories, indicates that early-onset pancreatic cancer could become one of the top global health challenges by 2040. While most diagnoses still occur after age 55, the trend among younger adults is driven by lifestyle factors including obesity, smoking, excessive alcohol consumption, and ultraprocessed food intake.
Despite this shift, advanced age remains a primary risk factor for the disease. In the United States, a national awareness campaign has been launched to address growing concerns about rising cases. Pancreatic cancer remains among the deadliest malignancies, with a five-year survival rate below 20%.
The disease is often called “silent” because it typically presents no symptoms in early stages and is not detected by routine blood tests or abdominal ultrasounds. When symptoms do appear — such as nausea, abdominal or back pain, unexplained weight loss, or jaundice — the cancer is usually advanced, contributing to high mortality.
In Brazil, the National Cancer Institute (Inca) estimates approximately 13,240 modern cases annually between 2026 and 2028. Prevention and individualized risk assessment are emphasized as essential strategies. Diagnostic confirmation relies on imaging and biopsy, including CT scans, MRI, endoscopic ultrasound, and tissue sampling.
High-risk groups include those with a family history of pancreatic cancer, BRCA gene mutations (also linked to breast, ovarian, and prostate cancers), type 2 diabetes (especially when diagnosed after age 40), persistent unexplained back pain, and individuals who smoke, drink alcohol frequently, or maintain poor diets.
A blood test highlighted in Jornal O candeeiro shows promise for detecting pancreatic cancer at earlier stages, though the article provides no further detail on the test’s mechanism, availability, or validation.
For more on this story, see Dr. Samadder: Expert in Hereditary Cancer and Endoscopic Oncology at Mayo Clinic.
The case of Lawrence Fox, a 67-year-old from Canterbury, England, illustrates the disease’s stealthy progression. In Easter 2023, he experienced persistent digestive discomfort and acid reflux, initially managing symptoms at home until back pain prompted hospitalization.
Emergency staff first suspected gallstones, but rapid clinical deterioration followed, including pronounced jaundice — yellowing of the skin and eyes — which triggered imaging and biopsy. The definitive diagnosis: pancreatic cancer.
Fox was told his life expectancy without treatment would be just nine months. He underwent a Whipple procedure (duodenopancreatectomy), involving removal of the gallbladder, part of the pancreas, and a segment of the intestine. After initial recovery, he completed six months of intensive chemotherapy.
Today, Fox is cancer-free but requires artificial enzyme supplements with every meal to aid digestion, as his pancreas no longer functions fully. His experience underscores how early symptoms can mimic common gastrointestinal issues, delaying oncological investigation.
This follows our earlier report, British adults seek to avoid ultra-processed foods but most cannot define them accurately.
According to Inca, key symptoms of pancreatic cancer include jaundice, abdominal or back pain, unexplained weight loss and loss of appetite, dark urine, and pale stools. Major risk factors are smoking, obesity, age over 60, family history, and diabetes.
Why is pancreatic cancer often diagnosed at an advanced stage?
Pancreatic cancer is frequently asymptomatic in early stages and not detectable through routine exams like blood tests or abdominal ultrasounds, meaning symptoms such as jaundice or pain typically appear only after the tumor has progressed.
What lifestyle factors are linked to rising pancreatic cancer rates in younger adults?
Obesity, smoking, excessive alcohol consumption, and diets high in ultraprocessed foods are identified as key lifestyle drivers behind the increasing incidence of pancreatic cancer in people under 50.
Can pancreatic cancer be detected early through blood tests?
One source notes a blood test that may improve early detection chances, but no details on its accuracy, availability, or clinical apply are provided in the source material.
What treatment did Lawrence Fox receive for pancreatic cancer?
Lawrence Fox underwent a Whipple procedure to remove the gallbladder, part of the pancreas, and a section of the intestine, followed by six months of chemotherapy after initial surgical recovery.